CLX · XBRL financial data

The Clorox Company financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (CLX's year ends in late June)

In millions of dollars	Q1 FY24Sep 30, 2023	Q2 FY24Dec 31, 2023	Q3 FY24Mar 31, 2024	Q4 FY24Jun 30, 2024	Q1 FY25Sep 30, 2024	Q2 FY25Dec 31, 2024	Q3 FY25Mar 31, 2025	Q4 FY25Jun 30, 2025	Q1 FY26Sep 30, 2025	Q2 FY26Dec 31, 2025	Q3 FY26Mar 31, 2026	Q1 FY27Sep 30, 2026
Revenue from contracts with customers	1,386	1,990	1,814	1,903*	1,762	1,686	1,668	1,988*	1,429	1,673	1,670	1,905
Cost of goods and services sold	854	1,124	1,048	1,019*	955	948	924	1,064*	833	951	948	1,135
Gross profit	532	866	766	884*	807	738	744	924*	596	722	722	770
Research and development	29	32	32	33*	31	31	27	32*	28	29	27	29
Selling, general and administrative	276	322	301	268*	281	280	267	296*	277	262	229	290
Interest expense	21	26	22	21*	21	22	23	22*	23	25	27	52
Income tax expense (benefit)	4	40	8	54*	74	43	63	74*	25	54	65	34
Net income (loss)	22	93	(51)	216*	99	193	186	332*	80	157	187	170
Earnings per share, basic USD per share	0.17	0.75	(0.41)	1.74*	0.80	1.55	1.51	2.70*	0.65	1.29	1.54	1.39
Earnings per share, diluted USD per share	0.17	0.75	(0.41)	1.72*	0.80	1.54	1.50	2.68*	0.65	1.29	1.54	1.39
Weighted average shares, basic millions of shares	124	124	124	124*	124	124	123	123*	123	122	121	122
Weighted average shares, diluted millions of shares	125	125	124	126*	125	125	124	124*	123	122	122	122

Balance sheet

CSV

Fiscal quarters (CLX's year ends in late June)

In millions of dollars	Q1 FY24Sep 30, 2023	Q2 FY24Dec 31, 2023	Q3 FY24Mar 31, 2024	Q4 FY24Jun 30, 2024	Q1 FY25Sep 30, 2024	Q2 FY25Dec 31, 2024	Q3 FY25Mar 31, 2025	Q4 FY25Jun 30, 2025	Q1 FY26Sep 30, 2025	Q2 FY26Dec 31, 2025	Q3 FY26Mar 31, 2026	Q1 FY27Sep 30, 2026
Cash and cash equivalents	518	355	219	202	278	290	226	167	166	227	1,187	184
Inventory	710	655	674	637	594	592	635	523	577	608	588	774
Prepaid and other current assets	102	115	95	88	109	147	132	97	249	222	205	228
Total current assets	1,911	1,804	1,661	1,622	1,576	1,632	1,590	1,608	1,695	1,728	2,651	1,931
Property and equipment, net	1,317	1,314	1,292	1,315	1,242	1,242	1,245	1,267	1,251	1,247	1,235	1,482
Right-of-use asset	328	354	379	360	341	362	349	333	318	368	355	384
Goodwill	1,246	1,252	1,229	1,228	1,233	1,219	1,222	1,229	1,227	1,231	1,229	1,944
Total assets	5,991	5,908	5,805	5,751	5,497	5,577	5,512	5,561	5,528	5,613	6,436	7,832
Accounts payable	—	—	—	950	—	—	—	838	—	—	—	—
Commercial paper	347	247	111	4	4	189	54	4	218	307	1,591	1,175
Current portion of long-term debt	—	—	—	0	—	—	—	0	—	—	—	1
Total current liabilities	2,228	2,022	1,846	1,574	1,579	1,730	2,155	1,919	2,234	2,347	3,155	2,954
Long-term debt	2,478	2,479	2,480	2,481	2,482	2,483	2,483	2,484	2,485	2,486	2,487	3,982
Lease liability, non-current	290	311	347	334	315	339	322	305	286	341	323	347
Total liabilities	5,860	5,690	5,550	5,259	5,273	5,456	5,322	5,079	5,390	5,578	6,344	7,711
Retained earnings	299	241	34	250	31	68	99	432	200	190	223	247
Total stockholders' equity	(37)	53	91	328	60	(41)	27	321	(22)	(125)	(67)	(39)
Total liabilities and equity	5,991	5,908	5,805	5,751	5,497	5,577	5,512	5,561	5,528	5,613	6,436	7,832
Common shares outstanding (cover page) millions of shares	124	124	124	124	124	123	123	122	122	121	121	121

Cash flows

CSV

Fiscal quarters (CLX's year ends in late June)

In millions of dollars	Q1 FY24Sep 30, 2023	Q2 FY24Dec 31, 2023	Q3 FY24Mar 31, 2024	Q4 FY24Jun 30, 2024	Q1 FY25Sep 30, 2024	Q2 FY25Dec 31, 2024	Q3 FY25Mar 31, 2025	Q4 FY25Jun 30, 2025	Q1 FY26Sep 30, 2025	Q2 FY26Dec 31, 2025	Q3 FY26Mar 31, 2026	Q1 FY27Sep 30, 2026
Net income (loss)	22	93	(51)	216*	99	193	186	332*	80	157	187	170
Stock-based compensation	13	16*	26*	19*	13	27	24	17*	10	24	15	9
Depreciation and amortization	61	57*	58*	59*	54	53	55	57*	56	55	58	74
Net cash from operating activities	20	153*	182*	340*	221	180*	286*	294*	93	311*	(122)*	143
Purchases of property and equipment	24	52*	55*	81*	39	53*	53*	75*	36	42*	43*	38
Net cash from investing activities	(23)	(33)*	(38)*	(81)*	89	(54)*	(53)*	(76)*	(34)	(43)*	(43)*	(35)
Share repurchases	0	0*	0*	0*	107	150*	0*	75*	129	127*	0*	0
Dividends paid	149	149*	148*	149*	151	151*	150*	150*	151	151*	150*	151
Proceeds from long-term debt	—	—	—	year only	—	—	—	—	—	—	—	—
Repayments of long-term debt	—	—	—	year only	—	—	—	—	—	—	—	—
Net cash from financing activities	155	(259)*	(278)*	(273)*	(237)	(109)*	(299)*	(279)*	(59)	(210)*	1,126*	(68)
Net change in cash	152	(162)*	(137)*	(14)*	75	12*	(65)*	(59)*	(1)	60*	958*	40

Compare with peers

SIC 2842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Clorox	184	1,905	143	121.1M	Q1 FY27 10-QSep 30, 2026
Church & Dwight	447	1,602	380*	236.0M	Q3 FY26 10-QSep 30, 2026
Estee Lauder Companies	3,198	3,715	(166)	not reported	Q1 FY27 10-QSep 30, 2026
Kenvue	1,039	3,886	700*	1.9B	Q3 FY26 10-QSep 27, 2026
Ecolab	722	4,695	764*	280.5M	Q3 FY26 10-QSep 30, 2026
Colgate Palmolive	1,527	5,369	1,171*	794.9M	Q3 FY26 10-QSep 30, 2026
e.l.f. Beauty	344	479	112	59.0M	Q1 FY27 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.